ICU
SeaStar Medical Holding Corp
NASDAQ · Healthcare · Biotechnology · US
$3.01
−1.63%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$3.16
From 52W high−52.30%
Volume70298.00
Market cap$15.84M
P/E (TTM)—
P/S (TTM)9.2x
Div yield—
Key dataOct 16, 2026
Open
$3.16
From 52W high
−52.30%
Volume
70298.00
Market cap
$15.84M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.9x
P/E (TTM)
—
RSI (14)
43.8
MomentumView details →
1D Return
−1.63%
YTD Return
+26.67%
SummaryUpdated Jun 1, 2026
SeaStar Medical Holding Corporation (NASDAQ:ICU) is a Denver-based medical device company that went public in March 2021. The company specializes in developing extracorporeal therapies designed to treat hyperinflammation and cytokine storm in critically ill patients. SeaStar focuses on targeting the cellular mechanisms that drive systemic inflammation, which can cause direct tissue damage and trigger cascading immune responses that worsen patient outcomes in intensive care settings.
Similar companies
Latest newsMore news →
SeaStar Medical Holding Corporation entered into definitive agreements on October 2, 2026 for the immediate exercise of outstanding warrants to purchase up to 854,002 shares of common stock at a reduced exercise price of $3.866 per share, raising approximately $3.3 million in gross proceeds.11d agoSeaStar Medical Holding Corporation announced that a late-breaking abstract on its post-approval SAVE Registry data was accepted for a poster presentation at ASN Kidney Week 2026 in Denver, October 21-25, 2026.14d ago